An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
The FDA and CDC have not yet determined for sure the source of the Cyclospora outbreak. It’s also not clear yet whether the rate of new Cyclosporiasis cases has slowed.
The FDA and CDC have not yet determined for sure the source of the Cyclospora outbreak. It’s also not clear yet whether the rate of new Cyclosporiasis cases has slowed.
A new American Heart Association statement redefines coffee’s impact on heart health, moving from historical caution to reassurance.
Healthcare has normalized click creep. Every extra checkbox steals attention from patients. It’s time for a Grand Declicking.
Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino? The honest answer is that it can be either.
Carrie Ann Inaba, longtime Dancing with the Stars judge and former co-host of The Talk, talked about the many challenges she has faced with Sjögren’s disease.
Record summer heat is transforming vacation into a survival season, severely impacting mental health and productivity.
Eli Lilly’s acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.
Eli Lilly’s acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.